Victory Capital Management’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-821
| Closed | -$3.78K | – | 2542 |
|
2023
Q2 | $3.78K | Buy |
821
+229
| +39% | +$1.05K | ﹤0.01% | 2507 |
|
2023
Q1 | $4.19K | Sell |
592
-34
| -5% | -$241 | ﹤0.01% | 2578 |
|
2022
Q4 | $4.02K | Hold |
626
| – | – | ﹤0.01% | 2571 |
|
2022
Q3 | $9K | Sell |
626
-132
| -17% | -$1.9K | ﹤0.01% | 2665 |
|
2022
Q2 | $14K | Sell |
758
-12
| -2% | -$222 | ﹤0.01% | 2636 |
|
2022
Q1 | $18K | Buy |
770
+139
| +22% | +$3.25K | ﹤0.01% | 2646 |
|
2021
Q4 | $27K | Sell |
631
-15
| -2% | -$642 | ﹤0.01% | 2677 |
|
2021
Q3 | $46K | Buy |
646
+16
| +3% | +$1.14K | ﹤0.01% | 2691 |
|
2021
Q2 | $72K | Sell |
630
-37
| -6% | -$4.23K | ﹤0.01% | 2638 |
|
2021
Q1 | $69K | Buy |
+667
| New | +$69K | ﹤0.01% | 2639 |
|
2020
Q2 | – | Sell |
-862
| Closed | -$42K | – | 3020 |
|
2020
Q1 | $42K | Buy |
+862
| New | +$42K | ﹤0.01% | 2841 |
|
2019
Q4 | – | Sell |
-290
| Closed | -$12K | – | 3054 |
|
2019
Q3 | $12K | Buy |
+290
| New | +$12K | ﹤0.01% | 3195 |
|